微血管健康状态作为放疗急性副作用的新型预测指标:跨三个瘤种的定量分析
该研究纳入314例乳腺癌、前列腺癌和头颈癌患者,放疗前用舌下显微镜无创评估微血管健康评分(MVHS)。总体人群中MVHS与急性放射性症状显著相关(OR=0.68,p=0.001),MVHS每降低1单位风险增加31.9%。乳腺癌亚组中剂量参数显著影响副作用风险,D20cc模型AUC最高(0.69),加入MVHS后提升至0.76。
要点
- 放疗前MVHS与急性放射性症状风险独立相关(OR=0.68,p=0.001)。
- MVHS每降低1单位,跨瘤种放射性症状风险增加31.9%。
- 乳腺癌亚组中D20cc模型加入MVHS后AUC由0.69提升至0.76。
核心结论
- 微血管健康状态与急性放射性症状风险显著相关,可用来改进预测模型并依据患者血管状态个体化治疗。
研究设计与样本
- 研究纳入314例乳腺癌、前列腺癌和头颈癌患者,放疗前用舌下显微镜记录微血管中红细胞视频并计算MVHS。
- MVHS单独及与剂量联合纳入逻辑回归模型,预测急性放射性副作用风险。
主要发现
- 总体人群中MVHS与副作用呈明确定量关联(OR=0.68,p=0.001)。
- MVHS每降低1单位,跨瘤种放射性症状风险增加31.9%。
- 乳腺癌亚组中,皮肤D200cc的OR为每1 Gy 1.05,D20cc的OR为每1 Gy 1.14,V20Gy的OR为每1 cc 1.01,均p<0.05。
- 乳腺癌亚组D20cc模型AUC最高为0.69,加入MVHS后提升至0.76。
关键数值与推荐
- MVHS与急性放射性症状关联的OR=0.68,p=0.001。
- MVHS每降低1单位,放射性症状风险增加31.9%。
- 乳腺癌亚组皮肤D200cc的OR=1.05每1 Gy,D20cc的OR=1.14每1 Gy,V20Gy的OR=1.01每1 cc,均p<0.05。
- 乳腺癌亚组D20cc模型AUC=0.69,加入MVHS后AUC=0.76。
临床怎么用
- 放疗前可用舌下显微镜无创评估MVHS,辅助识别急性副作用高危患者。
- 乳腺癌患者可结合皮肤剂量参数(D200cc、D20cc、V20Gy)与MVHS优化预测模型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To quantitatively assess how microvascular conditions estimated via a non-invasive method can predict acute side effects after radiotherapy in patients with breast, prostate, and head and neck cancers. MATERIALS AND METHODS: We studied 314 patients, assessing their MicroVascular Health Score (MVHS) before radiotherapy using a sublingual microscope that records videos of red blood cells in microvessels, analyses the microvasculature's functional and geometric properties, and calculates the MVHS. The MVHS was incorporated into a logistic model to predict the risk of developing acute radio-induced both alone and in combination with dose. RESULTS: A clear quantitative association between MVHS and side effects was observed in the overall population (OR = 0.68, p = 0.001). A 1-unit decrease in MVHS was associated with a 31.9% increased risk of radiation-induced symptoms across cancer sites. In the breast subgroup, dose factors significantly affected side effect risk (OR for D200cc to the skin: 1.05 per 1 Gy; OR for D20cc: 1.14 per 1 Gy; OR for V20Gy: 1.01 per 1 cc; all p < 0.05). The D20cc model had the highest AUC (0.69), and adding MVHS further improved it to 0.76. CONCLUSION: The study strongly linked microvascular health to the risk of acute radio-induced symptoms, suggesting that this could inform predictive models and customise treatments based on patient vascular status.
引用
- Catalano A, Materne S, Badenchini F, et al. Microvascular health status as a novel predictor of acute side effects after radiotherapy: a quantitative analysis across three cancer sites. Radiother Oncol. 2026. PMID: 42435814. doi:10.1016/j.radonc.2026.111693
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。